RYR2 and catecholaminergic polymorphic ventricular tachycardia: Dominant gain of function RYR2 variants occur in 60–70% of patients with the autosomal dominant pro-arrhythmic condition catecholaminergic polymorphic ventricular tachycardia (CPVT) [4].